泰格医药
(300347)
| 流通市值：312.55亿 | | | 总市值：475.29亿 |
| 流通股本：5.66亿 | | | 总股本：8.61亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,168,149,586.04 | 1,777,491,807.26 | 1,648,149,745.63 | 1,732,879,415.8 |
| 交易性金融资产 | 32,707,444.17 | 59,459,161.12 | 58,000,000 | 87,000,000 |
| 应收票据及应收账款 | 1,369,518,281.43 | 1,412,732,524.78 | 1,436,846,157.86 | 1,294,376,206.96 |
| 其中：应收票据 | 9,275,011.92 | 7,004,266.15 | 9,679,509.2 | 6,659,699.85 |
| 应收账款 | 1,360,243,269.51 | 1,405,728,258.63 | 1,427,166,648.66 | 1,287,716,507.11 |
| 应收款项融资 | 1,239,061.49 | 3,953,348.43 | - | - |
| 预付款项 | 121,535,508.28 | 122,972,634.86 | 142,175,462.53 | 120,899,963.88 |
| 其他应收款合计 | 109,453,807.44 | 109,395,716.23 | 188,040,915.78 | 112,504,518.66 |
| 其中:应收利息 | - | - | 2,447,188.11 | 352,639.85 |
| 存货 | 55,950,637.88 | 41,501,796.41 | 43,942,939.85 | 43,634,437.02 |
| 合同资产 | 2,708,380,363.28 | 2,584,975,822.49 | 2,779,362,851.14 | 2,751,249,863.14 |
| 其他流动资产 | 62,314,633.64 | 64,713,930.31 | 54,082,735.38 | 63,916,321 |
| 流动资产合计 | 6,629,249,323.65 | 6,177,196,741.89 | 6,350,600,808.17 | 6,206,460,726.46 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | 2,613,000 | - |
| 长期股权投资 | 4,439,142,469.73 | 4,498,839,308.43 | 4,092,975,746.66 | 4,078,243,679.08 |
| 其他权益工具投资 | 6,653,545.5 | 8,545,553.12 | 6,438,659.47 | 9,497,010.9 |
| 其他非流动金融资产 | 10,284,046,755.28 | 9,840,237,126.48 | 10,367,817,610.73 | 10,150,409,106.29 |
| 投资性房地产 | 14,356,069.14 | 15,388,440.06 | 16,124,831.72 | - |
| 固定资产 | 1,163,500,457.01 | 1,188,210,085.11 | 741,253,186.79 | 754,550,913.34 |
| 在建工程 | 132,713,179.56 | 110,604,207.57 | 478,389,559.38 | 464,682,655.15 |
| 使用权资产 | 384,499,710.95 | 408,905,731.66 | 414,940,010.49 | 451,925,960.46 |
| 无形资产 | 254,005,873.05 | 276,312,305.22 | 282,092,285.99 | 301,906,624.26 |
| 商誉 | 3,484,849,857.41 | 3,520,215,745.68 | 3,512,193,560.02 | 3,250,666,878.1 |
| 长期待摊费用 | 179,801,217.93 | 189,282,477.31 | 197,940,426.67 | 195,156,734.32 |
| 递延所得税资产 | 150,609,263.1 | 145,119,832.23 | 126,875,550.7 | 134,477,328.64 |
| 其他非流动资产 | 1,677,057,078.49 | 1,979,937,603.41 | 2,193,996,550.1 | 2,506,680,141.21 |
| 非流动资产合计 | 22,171,235,477.15 | 22,181,598,416.28 | 22,433,650,978.72 | 22,298,197,031.75 |
| 资产总计 | 28,800,484,800.8 | 28,358,795,158.17 | 28,784,251,786.89 | 28,504,657,758.21 |
| 流动负债: | | | | |
| 短期借款 | 404,947,667.71 | 511,020,767.84 | 601,815,467.81 | 1,439,391,704.42 |
| 应付票据及应付账款 | 336,565,849.72 | 371,118,244.78 | 343,819,887.57 | 313,002,724.89 |
| 其中：应付票据 | 6,090,170.14 | 5,889,386.05 | 5,889,386.07 | 6,135,272.21 |
| 应付账款 | 330,475,679.58 | 365,228,858.73 | 337,930,501.5 | 306,867,452.68 |
| 合同负债 | 1,251,417,957.21 | 1,079,154,504.24 | 1,103,392,114.97 | 943,308,269.82 |
| 应付职工薪酬 | 356,208,538.15 | 327,858,233.53 | 255,819,604.16 | 211,564,788.1 |
| 应交税费 | 205,938,183.63 | 231,541,815.12 | 139,601,225.19 | 139,717,560.39 |
| 其他应付款合计 | 84,244,049.23 | 74,461,840.09 | 248,763,935.3 | 104,096,443.29 |
| 其中:应付利息 | 1,567,912.2 | 1,388,432.36 | - | 3,334,127.35 |
| 应付股利 | 2,122,515.76 | 3,752,582.61 | 472,636.68 | 39,055,391.33 |
| 一年内到期的非流动负债 | 191,317,991.14 | 201,525,360.57 | 209,358,058.98 | 212,038,113.97 |
| 其他流动负债 | 49,039,050.72 | 38,793,286 | 35,282,719.06 | 32,569,687.89 |
| 流动负债合计 | 2,879,679,287.51 | 2,835,474,052.17 | 2,937,853,013.04 | 3,395,689,292.77 |
| 非流动负债: | | | | |
| 长期借款 | 691,647,009.48 | 510,560,589.95 | 526,629,225.57 | 556,783,178.07 |
| 应付债券 | 88,809,667.93 | 92,473,704.64 | 51,041,151.09 | - |
| 租赁负债 | 344,569,247.44 | 360,616,779.32 | 357,226,050.15 | 385,136,511.69 |
| 长期应付款 | 11,980,000 | 102,518,850 | 10,000,000 | - |
| 长期应付职工薪酬 | 10,172,418.98 | 10,897,307.43 | 2,731,588.57 | 2,980,183.53 |
| 递延收益 | 15,776,161.3 | 16,408,677.01 | 15,491,664.47 | 16,053,571.65 |
| 递延所得税负债 | 192,930,835.09 | 173,420,006.7 | 175,249,630.09 | 184,312,664.07 |
| 其他非流动负债 | - | - | 436,160.59 | - |
| 非流动负债合计 | 1,355,885,340.22 | 1,266,895,915.05 | 1,138,805,470.53 | 1,145,266,109.01 |
| 负债合计 | 4,235,564,627.73 | 4,102,369,967.22 | 4,076,658,483.57 | 4,540,955,401.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 861,026,050 | 861,026,050 | 861,026,050 | 861,026,050 |
| 资本公积 | 10,556,514,520.74 | 10,584,957,589.83 | 10,618,447,999.46 | 10,575,573,179.9 |
| 减:库存股 | 300,069,890 | 300,069,890 | 300,069,890 | 300,069,890 |
| 其他综合收益 | -6,635,437.99 | 57,068,522.37 | 107,866,176.97 | 135,941,239.17 |
| 盈余公积 | 436,529,393.76 | 436,529,393.76 | 436,529,393.76 | 436,529,393.76 |
| 未分配利润 | 9,369,037,969.94 | 9,319,994,848.81 | 9,452,538,930.31 | 8,815,441,906.34 |
| 归属于母公司股东权益合计 | 20,916,402,606.45 | 20,959,506,514.77 | 21,176,338,660.5 | 20,524,441,879.17 |
| 少数股东权益 | 3,648,517,566.62 | 3,296,918,676.18 | 3,531,254,642.82 | 3,439,260,477.26 |
| 股东权益合计 | 24,564,920,173.07 | 24,256,425,190.95 | 24,707,593,303.32 | 23,963,702,356.43 |
| 负债和股东权益合计 | 28,800,484,800.8 | 28,358,795,158.17 | 28,784,251,786.89 | 28,504,657,758.21 |
| 公告日期 | 2026-04-29 | 2026-03-31 | 2025-10-29 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |